LENZ Therapeutics, Inc. (LENZ)
2.965
-0.38
(-11.23%)
USD |
NASDAQ |
Nov 20, 16:00
2.96
0.00 (0.00%)
After-Hours: 20:00
LENZ Therapeutics Total Return Level : 3.154 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 3.154 |
| November 19, 2026 | 3.552 |
| November 18, 2026 | 3.414 |
| November 17, 2026 | 3.722 |
| November 16, 2026 | 4.063 |
| November 13, 2026 | 4.393 |
| November 12, 2026 | 4.35 |
| November 11, 2026 | 4.371 |
| November 10, 2026 | 4.361 |
| November 09, 2026 | 4.563 |
| November 06, 2026 | 3.722 |
| November 05, 2026 | 3.201 |
| November 04, 2026 | 3.68 |
| November 03, 2026 | 3.722 |
| November 02, 2026 | 3.244 |
| October 30, 2026 | 3.244 |
| October 29, 2026 | 3.712 |
| October 28, 2026 | 3.414 |
| October 27, 2026 | 3.350 |
| October 26, 2026 | 3.345 |
| October 23, 2026 | 3.361 |
| October 22, 2026 | 3.457 |
| October 21, 2026 | 3.425 |
| October 20, 2026 | 3.393 |
| October 19, 2026 | 3.510 |
| Date | Value |
|---|---|
| October 16, 2026 | 3.478 |
| October 15, 2026 | 3.797 |
| October 14, 2026 | 3.648 |
| October 13, 2026 | 3.616 |
| October 12, 2026 | 3.840 |
| October 09, 2026 | 3.877 |
| October 08, 2026 | 3.754 |
| October 07, 2026 | 3.850 |
| October 06, 2026 | 4.031 |
| October 05, 2026 | 3.818 |
| October 02, 2026 | 3.808 |
| October 01, 2026 | 4.031 |
| September 30, 2026 | 4.084 |
| September 29, 2026 | 4.105 |
| September 28, 2026 | 4.212 |
| September 25, 2026 | 4.164 |
| September 24, 2026 | 3.956 |
| September 23, 2026 | 3.999 |
| September 22, 2026 | 4.393 |
| September 21, 2026 | 4.339 |
| September 18, 2026 | 4.329 |
| September 17, 2026 | 4.393 |
| September 16, 2026 | 4.403 |
| September 15, 2026 | 4.499 |
| September 14, 2026 | 4.754 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| EyePoint, Inc. | 0.2342 |
| Ligand Pharmaceuticals, Inc. | 381.71 |
| Bristol Myers Squibb Co. | 224.76 |
| Context Therapeutics, Inc. | 0.16 |
| Neumora Therapeutics, Inc. | 0.3339 |